In this Applied Clinical Trials blog, Aman Khera shares her perspective on CTTI’s vision for the future of clinical trials, and how COVID-19 has impacted the industry.

With significant variations in the effects of COVID-19 among various ethnic, racial, and minority groups, how do we ensure vaccine trials are accurately establishing efficacy and safety across all patient populations? Beyond the ethical considerations, diversity is a medical and scientific imperative. This peer-reviewed article identifies tools and considerations for achieving representative diversity in enrolment for COVID-19 vaccine registration trials.

Read this article about findings from the most recent Biopharma Confidence Index that show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.

Read this article about findings from the most recent Biopharma Confidence Index that show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.

In this Pharmaceutical Outsourcing article, Aman Khera describes how the coronavirus health crisis has brought attention to global regulatory challenges impacting drug development.

In a recent Journal for Clinical Studies article, Aman Khera and Henry J. Riordan, Ph.D., discuss recent guidance, operational processes and best practices designed by regulatory bodies to accelerate drug product development during COVID-19.